NCT07019090: Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- State
- Not started
- Phase
- Phase 2
- People
- 120 planned
- Started
- 27 Jun 2025
- Primary completion
- 31 Oct 2026
- Arms
- HSK44459
- Results
- None posted
- 13 Jun 2025: Trial registered